Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

559 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Palliative Radiotherapy for Diffuse Large B-cell Lymphoma.
Wright CM, Koroulakis AI, Baron JA, Chong EA, Tseng YD, Kurtz G, LaRiviere M, Venigalla S, Jones JA, Maity A, Mohindra P, Plastaras JP, Paydar I. Wright CM, et al. Among authors: baron ja. Clin Lymphoma Myeloma Leuk. 2021 Oct;21(10):650-658. doi: 10.1016/j.clml.2021.05.007. Epub 2021 May 19. Clin Lymphoma Myeloma Leuk. 2021. PMID: 34127417 Review.
Bridging Radiation Therapy Before Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Aggressive B-Cell Lymphoma.
Wright CM, LaRiviere MJ, Baron JA, Uche C, Xiao Y, Arscott WT, Anstadt EJ, Barsky AR, Miller D, LaRose MI, Landsburg DJ, Svoboda J, Nasta SD, Gerson JN, Barta SK, Chong EA, Schuster SJ, Paydar I, Maity A, Plastaras JP. Wright CM, et al. Among authors: baron ja. Int J Radiat Oncol Biol Phys. 2020 Sep 1;108(1):178-188. doi: 10.1016/j.ijrobp.2020.05.014. Epub 2020 May 22. Int J Radiat Oncol Biol Phys. 2020. PMID: 32446950
Radiation Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma: What Is the Right Regimen for Palliation?
Wright CM, Dreyfuss AD, Baron JA, Maxwell R, Mendes A, Barsky AR, Doucette A, Svoboda J, Chong EA, Jones JA, Maity A, Plastaras JP, Paydar I. Wright CM, et al. Among authors: baron ja. Adv Radiat Oncol. 2022 Jul 3;7(6):101016. doi: 10.1016/j.adro.2022.101016. eCollection 2022 Nov-Dec. Adv Radiat Oncol. 2022. PMID: 36420208 Free PMC article.
Proton Radiation Therapy After Chemotherapy in the Management of Aggressive Mediastinal Non-Hodgkin Lymphomas: A Particle Therapy Cooperative Group Lymphoma Subcommittee Collaboration.
Baron JA, Wright CM, Maxwell R, Kim MM, Giap F, Vega RBM, Hoppe BS, LaRiviere MJ, Maity A, Plastaras JP, Paydar I. Baron JA, et al. Adv Radiat Oncol. 2022 Oct 3;8(1):101090. doi: 10.1016/j.adro.2022.101090. eCollection 2023 Jan-Feb. Adv Radiat Oncol. 2022. PMID: 36530648 Free PMC article.
Salvage radiotherapy for relapsed/refractory non-Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapy.
Yegya-Raman N, Wright CM, LaRiviere MJ, Baron JA, Lee DY, Landsburg DJ, Svoboda J, Nasta SD, Gerson JN, Barta SK, Chong EA, Schuster SJ, Maity A, Facciabene A, Paydar I, Plastaras JP. Yegya-Raman N, et al. Among authors: baron ja. Clin Transl Radiat Oncol. 2023 Jan 20;39:100587. doi: 10.1016/j.ctro.2023.100587. eCollection 2023 Mar. Clin Transl Radiat Oncol. 2023. PMID: 36718252 Free PMC article.
Contingent valuation: Flawed logic?
Baron J. Baron J. Science. 2017 Jul 28;357(6349):363. doi: 10.1126/science.aan6594. Science. 2017. PMID: 28751599 No abstract available.
559 results